doi: 10.1007/978-3-642-80997-2_8.
The WHO classification of bone tumors
- PMID: 1070715
- DOI: 10.1007/978-3-642-80997-2_8
Item in Clipboard
The WHO classification of bone tumors
Recent Results Cancer Res.
1976.
Abstract
The WHO scheme of classification of bone tumors is based on histologic criteria. It simply lists the main types of primary bone tumors; knowledge of histogenesis or of tumor origin is implied only for certain groups of lesions. This international agreement on nomenclature and classification of bone tumors would greatly aid comparative population studies on bone tumors in different parts of the world.
Similar articles
-
[Classification of primary bone tumors].Zentralbl Allg Pathol. 1986;131(5):411-6. Zentralbl Allg Pathol. 1986. PMID: 3461626 German.
-
[Cytological classification of bone tumors].Arkh Patol. 1985;47(9):35-9. Arkh Patol. 1985. PMID: 3907598 Russian.
-
[The international classification of bone tumors and some remarks concerning it].Arkh Patol. 1975;37(2):34-7. Arkh Patol. 1975. PMID: 1131055 Russian.
-
The 2020 WHO Classification of Tumors of Bone: An Updated Review.Adv Anat Pathol. 2021 May 1;28(3):119-138. doi: 10.1097/PAP.0000000000000293. Adv Anat Pathol. 2021. PMID: 33480599 Review.
-
Classification and grading of bone sarcomas.Hematol Oncol Clin North Am. 1995 Jun;9(3):545-69. Hematol Oncol Clin North Am. 1995. PMID: 7649942 Review.
Cited by
-
Review of Osteosarcoma and Current Management.Rheumatol Ther. 2016 Dec;3(2):221-243. doi: 10.1007/s40744-016-0046-y. Epub 2016 Oct 19. Rheumatol Ther. 2016. PMID: 27761754 Free PMC article. Review.
-
MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.Mol Med Rep. 2020 Nov;22(5):3911-3921. doi: 10.3892/mmr.2020.11447. Epub 2020 Aug 20. Mol Med Rep. 2020. PMID: 33000186 Free PMC article.
-
Osteosarcoma: mouse models, cell of origin and cancer stem cell.Postdoc J. 2014 Feb;2(2):19-30. doi: 10.14304/surya.jpr.v2n2.3. Postdoc J. 2014. PMID: 27617267 Free PMC article.
-
[Classification and morphology of bone tumours].Langenbecks Arch Chir. 1982;358:359-67. doi: 10.1007/BF01271819. Langenbecks Arch Chir. 1982. PMID: 6963360 German. No abstract available.
-
SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.Mol Cancer Ther. 2024 Feb 1;23(2):223-234. doi: 10.1158/1535-7163.MCT-23-0173. Mol Cancer Ther. 2024. PMID: 37871911 Free PMC article.